AI assistant
Sending…
BIO-RAD LABORATORIES, INC. — Director's Dealing 2017
Sep 13, 2017
30786_dirs_2017-09-13_a7f784e8-c8dc-4d43-91a6-c71ccff48a02.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2017-09-11
Reporting Person: Crowley Michael (EVP, GBL Commercial Operations)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2017-09-11 | Bio-Rad A Common Stock | M | 976 | — | Acquired | 3652 | Direct |
| 2017-09-11 | Bio-Rad A Common Stock | F | 368 | $218.86 | Disposed | 3284 | Direct |
| 2017-09-12 | Bio-Rad A Common Stock | M | 334 | — | Acquired | 3618 | Direct |
| 2017-09-12 | Bio-Rad A Common Stock | F | 126 | $218.04 | Disposed | 3492 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2017-09-11 | Restricted Stock Units | $0 | M | 376 | Disposed | Bio-Rad A Common Stock (376) | Direct | |
| 2017-09-11 | Restricted Stock Units | $0 | M | 600 | Disposed | Bio-Rad A Common Stock (600) | Direct | |
| 2017-09-12 | Restricted Stock Units | $0 | M | 334 | Disposed | Bio-Rad A Common Stock (334) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F3: The restricted stock units vest in five equal annual installments beginning September 11, 2014.
F4: The restricted stock units vest in five equal annual installments beginning September 11, 2016.
F5: The restricted stock units vest in five equal annual installments beginning September 12, 2013.
More from BIO-RAD LABORATORIES, INC.
Regulatory Filings
2026
May 13
Regulatory Filings
2026
Apr 30
Interim / Quarterly Report
2026
Apr 30
Regulatory Filings
2026
Apr 30
Regulatory Filings
2026
Apr 24
Major Shareholding Notification
2026
Mar 26
Annual Report
2026
Mar 25
Proxy Solicitation & Information Statement
2026
Mar 25
Regulatory Filings
2026
Feb 19
Annual Report
2026
Feb 13